This from MEDPAGE TODAY:

“Compared with 2008, costs for brand-name anti seizure meds (ADMs) rose from approximately $2,800 to $10,700 per year in 2018, while costs for generic brand ASMs dropped $800 to $460. As a result, many generic ASMs cost about 10 times less than their brand-name counterparts.

For example, generic levetiracetam cost $540 per year, while brand-name levetiracetam (Keppra) was $6,900. Likewise, a 1-year supply of generic lamotrigine was $600, but a 1-year supply of brand-name lamotrigine (Lamictal) was $9,000…”

To find out more, click on: https://www.medpagetoday.com/neurology/seizures/99268

To subscribe to Epilepsy Talk and get the latest articles, simply go to the bottom box of the right column, enter your email address and click on “Follow”